3/3
06:13 pm
indv
Indivior (INDV) was upgraded by
Weiss Ratings from "hold (c)" to "buy (b-)".
Medium
Report
Indivior (INDV) was upgraded by
Weiss Ratings from "hold (c)" to "buy (b-)".
2/27
07:13 am
indv
Indivior PLC Q4 2025 Earnings Call Summary [Yahoo! Finance]
Medium
Report
Indivior PLC Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/27
12:00 am
indv
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Recent Name Change [Yahoo! Finance]
Medium
Report
A Look At Indivior Pharmaceuticals (NasdaqGS:INDV) Valuation After Its Recent Name Change [Yahoo! Finance]
2/26
09:43 am
indv
Indivior Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Indivior Q4 Earnings Call Highlights [Yahoo! Finance]
2/26
07:09 am
indv
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
Medium
Report
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]
2/26
07:00 am
indv
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
Low
Report
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
2/24
07:00 am
indv
Indivior to Participate in Upcoming Investor Conferences
Low
Report
Indivior to Participate in Upcoming Investor Conferences
1/30
06:06 am
indv
Indivior (NASDAQ:INDV) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings .
Low
Report
Indivior (NASDAQ:INDV) had its "hold (c)" rating reaffirmed by analysts at
Weiss Ratings .
2/26/2026
07:00 am
indv
indivior plc - ordinary shares
BEAT
Report
-6.4%
indivior plc - ordinary shares
10/30/2025
07:00 am
indv
indivior plc - ordinary shares
BEAT
Report
0.3%
indivior plc - ordinary shares
7/31/2025
07:00 am
indv
indivior plc - ordinary shares
BEAT
Report
13.2%
indivior plc - ordinary shares
3/5
04:01 pm
indv
Form 4 Indivior Pharmaceuticals For: Mar 03 Filed by: Anderson Woodrow D
Low
Report
Form 4 Indivior Pharmaceuticals For: Mar 03 Filed by: Anderson Woodrow D
3/5
04:00 pm
indv
Form 4 Indivior Pharmaceuticals For: Mar 03 Filed by: Preblick Ryan
Low
Report
Form 4 Indivior Pharmaceuticals For: Mar 03 Filed by: Preblick Ryan
3/5
04:00 pm
indv
Form 4 Indivior Pharmaceuticals For: Mar 03 Filed by: Burris Jeffrey W
Low
Report
Form 4 Indivior Pharmaceuticals For: Mar 03 Filed by: Burris Jeffrey W
3/5
03:59 pm
indv
Form 4 Indivior Pharmaceuticals For: Mar 03 Filed by: Heidbreder Christian
Low
Report
Form 4 Indivior Pharmaceuticals For: Mar 03 Filed by: Heidbreder Christian
2/26
04:05 pm
indv
Form 10-K Indivior Pharmaceuticals For: Dec 31
Medium
Report
Form 10-K Indivior Pharmaceuticals For: Dec 31
2/26
07:01 am
indv
Form 8-K Indivior Pharmaceuticals For: Feb 26
Low
Report
Form 8-K Indivior Pharmaceuticals For: Feb 26
2/17
04:58 pm
indv
Form SCHEDULE 13G/A Indivior Pharmaceuticals Filed by: Madison Avenue Partners, LP
Low
Report
Form SCHEDULE 13G/A Indivior Pharmaceuticals Filed by: Madison Avenue Partners, LP
2/17
01:38 pm
indv
Form SCHEDULE 13G Indivior Pharmaceuticals Filed by: FULLER & THALER ASSET MANAGEMENT, INC.
Low
Report
Form SCHEDULE 13G Indivior Pharmaceuticals Filed by: FULLER & THALER ASSET MANAGEMENT, INC.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register